View Item 

Show simple item record

3 H Dendrimer Nanoparticle Organ/Tumor Distribution
dc.contributor.authorNigavekar, Shraddha S.en_US
dc.contributor.authorLlanes, Mikelen_US
dc.contributor.authorKhan, Mohamed K.en_US
dc.contributor.authorEl-Jawahri, Areejen_US
dc.contributor.authorBecker, Christopher W.en_US
dc.contributor.authorBalogh, Lajos P.en_US
dc.contributor.authorSung, Lok Yunen_US
dc.contributor.authorLawrence, Theodore S.en_US
dc.date.accessioned2006-09-08T19:19:50Z
dc.date.available2006-09-08T19:19:50Z
dc.date.issued2004-03en_US
dc.identifier.citationNigavekar, Shraddha S.; Sung, Lok Yun; Llanes, Mikel; El-Jawahri, Areej; Lawrence, Theodore S.; Becker, Christopher W.; Balogh, Lajos; Khan, Mohamed K.; (2004). " 3 H Dendrimer Nanoparticle Organ/Tumor Distribution." Pharmaceutical Research 21(3): 476-483. <http://hdl.handle.net/2027.42/41504>en_US
dc.identifier.issn1573-904Xen_US
dc.identifier.issn0724-8741en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/41504
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15070099&dopt=citationen_US
dc.description.abstractPurpose. To determine the in vivo biodistribution for differently charged poly(amidoamine) (PAMAM) dendrimers in B16 melanoma and DU145 human prostate cancer mouse tumor model systems.en_US
dc.format.extent277086 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Mediaen_US
dc.subject.otherMelanomaen_US
dc.subject.otherProstate Canceren_US
dc.subject.otherPAMAM Dendrimersen_US
dc.subject.otherTritiated Nanoparticlesen_US
dc.subject.otherBiomedical Engineeringen_US
dc.subject.otherBiodistributionen_US
dc.subject.otherPharmacyen_US
dc.subject.otherMedical Lawen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.subject.otherBiochemistry, Generalen_US
dc.title3 H Dendrimer Nanoparticle Organ/Tumor Distributionen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Radiation Oncology, University of Michigan, Ann Arbor, MI, 48109en_US
dc.contributor.affiliationumDepartment of Radiation Oncology, University of Michigan, Ann Arbor, MI, 48109en_US
dc.contributor.affiliationumDepartment of Radiation Oncology, University of Michigan, Ann Arbor, MI, 48109en_US
dc.contributor.affiliationumDepartment of Radiation Oncology, University of Michigan, Ann Arbor, MI, 48109en_US
dc.contributor.affiliationumDepartment of Radiation Oncology, University of Michigan, Ann Arbor, MI, 48109en_US
dc.contributor.affiliationumDepartment of Internal Medicine, Center for Biologic Nanotechnology, University of Michigan, Ann Arbor, MI, 48109en_US
dc.contributor.affiliationumMichigan Memorial Phoenix Project, University of Michigan, Ann Arbor, MI, 48109en_US
dc.contributor.affiliationumDepartment of Radiation Oncology, University of Michigan, Ann Arbor, MI, 48109en_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid15070099en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/41504/1/11095_2004_Article_482250.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1023/B:PHAM.0000019302.26097.ccen_US
dc.identifier.sourcePharmaceutical Researchen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
11095_2004_Article_482250.pdf
Size:
270.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.